# Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)

> **NCT00686790** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 68 (actual)

## Conditions studied

- Hepatitis D, Chronic
- Hepatitis B, Chronic

## Interventions

- **BIOLOGICAL:** Peginterferon alfa-2b (PegIntron, SCH 54031)

## Key facts

- **NCT ID:** NCT00686790
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2017-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00686790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00686790, "Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00686790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*